Cholinergic control of Th17 cell pathogenicity in experimental autoimmune encephalomyelitis-Reference-Cited by-同舟云学术

Cholinergic control of Th17 cell pathogenicity in experimental autoimmune encephalomyelitis

Published:2022-12-17 Issue:2 Volume:30 Page:407-416
ISSN:1350-9047
Container-title:Cell Death & Differentiation
language:en
Short-container-title:Cell Death Differ

Author:

Nechanitzky Robert,Nechanitzky Duygu,Ramachandran Parameswaran,Duncan Gordon S.,Zheng Chunxing,Göbl Christoph,Gill Kyle T.,Haight Jillian,Wakeham Andrew C.,Snow Bryan E.,Bradaschia-Correa Vivian,Ganguly Milan,Lu Zhibin^ORCID,Saunders Mary E.,Flavell Richard A.^ORCID,Mak Tak W.^ORCID

Funder

Gouvernement du Canada | Instituts de Recherche en Santé du Canada | CIHR Skin Research Training Centre

European Molecular Biology Organization

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology

Link

https://www.nature.com/articles/s41418-022-01092-y.pdf

Reference82 articles.

1. Oda Y. Choline acetyltransferase: the structure, distribution and pathologic changes in the central nervous system. Pathol Int. 1999;49:921–37.

2. Cox MA, Bassi C, Saunders ME, Nechanitzky R, Morgado-Palacin I, Zheng C, et al. Beyond neurotransmission: acetylcholine in immunity and inflammation. J Intern Med. 2020;287:120–33.